Head and neck malignancies are frequently aggressive with high recurrence rates. These
tumors are usually treated with surgical resection and/or radiation therapy. Patients
treated initially with a free tissue transfer may require resection of the free flap
if involved with recurrent tumor. This may result in a defect that requires a second
free tissue transfer. These reconstructions may be technically difficult, and sometimes
impossible, because of post-radiation changes, scarring from previous neck dissections,
the presence of the initial free flap, or absence of quality recipient vessels for
microvascular anastomosis.
The authors reported their experience with second free tissue transfers in 12 patients
with recurrent head and neck malignancy who previously underwent free flap reconstruction
of the same region over a 15-year period at the Mayo Clinic, Rochester, from 1988
to 2003. All recurrences involved the original free flap which, therefore, needed
resection. The patients included 5 men and 7 women, with an average age of 55 years
(35–73), who underwent 25 free flaps for this indication. The most common pathologic
diagnosis was squamous cell carcinoma (n =ߙ7). The most common free flap used for
the second reconstruction was the rectus abdominis muscle (n =ߙ4). The overall flap
survival rate was 92%, with a 100% survival rate in the first free tissue transfer
and 85% survival rate in the second transfer. The overall complication rate in the
second free flaps was 23% (3 of 13 flaps). There was one minor complication (8%) which
was a wound infection at a fibula harvest site; and two major complications (15%),
including a failed fibula osteocutaneous flap in one patient and a myocardial infarction
in another. Overall, 10 of 13 (77%) second free flaps were anastomosed to ipsilateral
neck vessels. Moreover, in 5 of 13 (38%) of the cases the same artery, and in 7 of
13 (54%) the same vein were utilized for both the first and second free flaps.
Reconstruction of the head and neck with a second free flap in patients with a recurrent
tumor is safe and effective, with the original recipient vessels often being used
for the second reconstruction.